Copyright © 2021. Inderes Oyj. All rights reserved.
Etsi
Käyttäjätili

Hei anonyymi!

Luomalla maksuttoman Inderes-tilin, pääset käsiksi Inderesin analyysiin, voit tilata suositun aamukatsauksen ja seurata sinua kiinnostavia yhtiöitä sekä keskusteluita.

Luo ilmainen tili

Onko sinulla jo Inderes-tili?

Carasent ASA

Analyytikko

Foorumi

Tästä Foorumille

Sisäpiirin kaupat

Nettovaikuttavuus

Artikkeli
Yhtiöjulkaisu
Muut analyysit
Carasent: Daniel Öhman appointed new CEO - Redeye
16.6.
2022

Redeye comments on the news of Daniel Öhman being appointed as the new CEO of Carasent, following Dennis Höjer's decision to step down earlier this year. Mr. Öhman is currently the CEO of GHP Speciality Care.

Tiedotteet
Carasent ASA: Daniel Öhman appointed new CEO
16.6.
2022 
June 16, 2022

The board of directors of Carasent ASA ("Carasent" or "the Company") has today
appointed Daniel Öhman as the Company's new Chief Executive Officer (CEO). He
will succeed Dennis Höjer who has been CEO since December 2020. Öhman will start
no later than 2 January 2023. 

Daniel Öhman is at present CEO of GHP Speciality Care, a role he has held since
2013. During Öhman's leadership, GHP Specialty Care's valuation increased from
370 MSEK to 2 450 MSEK, turnover doubled, and EBITDA increased from 50 MSEK to
200 MSEK.
Muut analyysit
Carasent: Webdoc NO a Litmus Test for Carasent’s Extensive Capex Initiatives - Redeye
20.5.
2022

Redeye updates its estimates following Carasent’s Q1 report and comments on topics ranging from the heavy capex cycle to CEO Dennis Höjer’s decision to step down.

Tiedotteet
Redeye: Carasent - Webdoc NO a Litmus Test for Carasent’s Extensive Capex Initiatives
20.5.
2022

Redeye updates its estimates following Carasent’s Q1 report and comments on topics ranging from the heavy capex cycle to CEO Dennis Höjer’s decision to step down. We expect Webdoc NO to be launched in Q2 2022 and its launch and successive ramp-up will be a litmus test for the Webdoc platform and the current spending levels.

Read more and download the Research Update.

Tiedotteet
Carasent: Minutes from Annual Shareholder Meeting
28.4.
2022 
Attached please find Minutes from today's Annual Shareholder Meeting, with
attachment.

All items on the agenda was resolved as prosposed in the Calling Notice.

For further information, please contact Johan Lindqvist, Chairman of the Board
phone: + 46 73 355 0935.
Muut analyysit
Carasent Q1’22: Initial take - Redeye
28.4.
2022

Redeye comments on Carasent’s Q1 report, which was solid albeit somewhat below our sales estimates. Margins and customer intake were in line.

Tiedotteet
Carasent: Q1 2022 Financial Result Presentation
28.4.
2022 
Attached please find Carasent ASA Q1 2022 Financial Result Presentation.

For further information, please contact 
CFO Svein Martin Bjørnstad, tel: 47 979 69 493
Tiedotteet
Carasent: CEO Dennis Højer to step down
28.4.
2022 
Attached please find release regarding CEO Dennis Højer stepping down.

For further information, please contact the 
Chairman of the Board Johan Lindqvist, 
tel: + 46 73355 0935.
Tiedotteet
Carasent: Q1-2022 Financial Report
28.4.
2022 
Attached please find Carasent ASA Financial Report for Q1/2022.

For further information, please contact 
CFO Svein Martin Bjørnstad, tel: 47 979 69 493
Tiedotteet
Carasent: Invitation to Q1, 2022 Financial Results Presentation
25.4.
2022 
Carasent ASA will present its Q1, 2022 Financial Results as a webcast on April
28, at 8:00 a.m.

Please use the following link for the webcast:

https://channel.royalcast.com/landingpage/hegnarmedia/20220428_2/

Carasent ASA